A carregar...
Factor VIII inhibitors in hemophilia A: rationale and latest evidence
Factor VIII (FVIII) replacement therapy is the foundation of treatment in hemophilia A and is effective unless a patient develops an alloantibody (inhibitor) against exogenous FVIII. Inhibitor development is currently the most significant treatment complication seen in patients with hemophilia and i...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629762/ https://ncbi.nlm.nih.gov/pubmed/23610614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712464509 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|